We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

84 hedge funds and large institutions have $83.3M invested in TriSalus Life Sciences in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

79% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 14

25% more funds holding

Funds holding: 67 → 84 (+17)

11.08% more ownership

Funds ownership: 22.88% → 33.96% (+11%)

4% more capital invested

Capital invested by funds: $79.8M → $83.3M (+$3.48M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
84
Holders Change
+17
Holders Change %
+25.37%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
29
Increased
25
Reduced
14
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FLAM
First Light Asset Management
Minnesota
+$24.8M
2
WA
Wasatch Advisors
Utah
+$7.04M
3
AIC
AWM Investment Company
New York
+$4.09M
4
Cerity Partners
Cerity Partners
New York
+$3.85M
5
TSW
Thompson Siegel & Walmsley
Virginia
+$2.86M

Top Sellers

Rank Fund Capital Flow
1
WAP
Wealthcare Advisory Partners
Pennsylvania
-$4.49M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.84M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$443K
4
Squarepoint
Squarepoint
New York
-$310K
5
Millennium Management
Millennium Management
New York
-$249K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$300K +$44.5K +9,081 +14%
CAMG
27
CWA Asset Management Group
Florida
$288K – – –
BCM
28
Bridgeway Capital Management
Texas
$278K – – –
SEI Investments
29
SEI Investments
Pennsylvania
$275K +$337K +68,870 New
IB
30
Intrust Bank
Kansas
$264K +$323K +66,000 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$263K +$5.88K +1,200 +2%
FG
32
Formula Growth
Quebec, Canada
$200K +$245K +50,000 New
MP
33
MSD Partners
New York
$160K – – –
N
34
Nuveen
North Carolina
$146K – – –
HWM
35
HighMark Wealth Management
Minnesota
$133K +$110K +22,500 +208%
Renaissance Technologies
36
Renaissance Technologies
New York
$124K +$151K +30,900 New
Deutsche Bank
37
Deutsche Bank
Germany
$115K +$25.1K +5,125 +22%
GCM
38
Ghisallo Capital Management
Massachusetts
$100K +$122K +25,000 New
Man Group
39
Man Group
United Kingdom
$93.4K +$42.8K +8,738 +60%
CWM
40
Connecticut Wealth Management
Connecticut
$89.2K – – –
CAPTRUST Financial Advisors
41
CAPTRUST Financial Advisors
North Carolina
$87.9K +$641 +131 +0.6%
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
$86K +$31.7K +6,480 +44%
XT
43
XTX Topco
Cayman Islands
$76.1K +$93.1K +19,014 New
Cambridge Investment Research Advisors
44
Cambridge Investment Research Advisors
Iowa
$62K – – –
VGA
45
Vanguard Global Advisers
Pennsylvania
$61.1K +$74.8K +15,268 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$60.2K -$1.89K -386 -3%
Mirae Asset Global ETFs Holdings
47
Mirae Asset Global ETFs Holdings
Hong Kong
$57.7K +$1.47K +300 +2%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$52K +$63.6K +12,994 New
Invesco
49
Invesco
Georgia
$46.3K +$6.22K +1,271 +12%
Wells Fargo
50
Wells Fargo
California
$46K -$115K -23,407 -67%
1
2
3 4

TLSI Hedge Fund Activity: Q1 2026 in Review

84 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q1 2026, worth a combined $83.3M — up 4.4% from $79.8M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TLSI positions and 10 closed out — a net gain of 19 holders — while 25 added to existing stakes and 14 trimmed.

The largest buyer was First Light Asset Management, opening a new position worth an estimated $24.8M. The largest seller was Wealthcare Advisory Partners, exiting entirely with an estimated $4.49M sold.

  • 84 institutional investors held TriSalus Life Sciences (TLSI) as of Q1 2026, up from 67 in Q4 2025.
  • Funds reported $83.3M of TriSalus Life Sciences stock for Q1 2026, up 4.4% quarter-over-quarter.
  • 29 funds opened new TriSalus Life Sciences positions in Q1 2026 and 10 closed out, a net change of +19 holders.
  • The largest TriSalus Life Sciences buyer in Q1 2026 was First Light Asset Management, an estimated $24.8M added.
  • The largest TriSalus Life Sciences seller in Q1 2026 was Wealthcare Advisory Partners, an estimated $4.49M sold.

Based on aggregated 13F filings for Q1 2026.